EpiPen price increases causes turmoil among allergy sufferers

Austin, TX – June 20, 2016 –  Epinephrine pens (commonly referred to as EpiPens) are extremely important for the health of anyone with severe allergies. Recently the main competitor of the EpiPen, Auvi-Q, recalled the products and stopped production last year. Now EpiPens are increasing in price and people are frustrated.

“There’s not a cost war anymore, so they can do what they want with the price,” said Sunny Kallmer, a physician assistant with Texan Allergy & Sinus Center. “And now it’s gone up. It used to be about $400 per EpiPen and they come in a two-pack. Whereas, now, I’m seeing more $500 and $600.”

The final cost of EpiPens will depend a lot on personal insurance and their website has coupons available as well.

About Texan Allergy & Sinus Center:

Texan Allergy & Sinus Center is a statewide allergy and sinus clinic that started in 2012 under the care and supervision of Dr. Christopher Thompson. The company has grown exponentially since then, adding several locations in Austin, San Antonio, Waco, Midland, El Paso, and Dallas-Fort Worth. Having cared for tens of thousands of patients, Texan Allergy & Sinus Center specializes in sublingual immunotherapy for allergies by creating personalized allergy drops that can be taken by severely allergic patients of all ages.

About Sunny Kallmer, MPAS, PA-C:

Sunny Kallmer graduated with distinction from the University of Nebraska Medical Center in Omaha in 1994, with a Master of Physician Assistant Studies. She’s been a proud Texan ever since. After working in family practice for close to 20 years, she learned and appreciated the huge burden that allergies have on health and quality of life.

At Texan Allergy & Sinus Center, she is motivated to best address allergies at their origin, rather than just managing the complications of secondary infections, eczema, asthma, and overall suffering. Sunny is passionate in practicing preventive medicine and optimizing quality of life.

###

Press Coverage

Rising costs of EpiPens causes concerns